AI technology could play a vital rule in the diagnosis and treatment of aggressive posterior retinopathy of prematurity (AP-ROP) in infants, according to new research published in Ophthalmology.
SymphonyAI Group, a private group of companies specializing in AI, announced Wednesday, March 4, that it has acquired TeraRecon. No financial details have been shared at this time.
Augmented reality (AR) technology could play a pivotal role in the interventional radiology (IR) suite of the future, according to a new study published in the Journal of Vascular and Interventional Radiology.
Proscia, a Philadelphia-based AI technology company, has partnered with the University of California, San Francisco (UCSF) to improve cancer diagnoses and patient outcomes.
AI technology could be a game-changer for the diagnosis and treatment of sleep disorders, according to a new statement from the American Academy of Sleep Medicine (AASM).